Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C5XF
|
||||
Former ID |
DIB008914
|
||||
Drug Name |
GSK-1344386B
|
||||
Synonyms |
CCR2 antagonist (atherosclerosis); GSK-1344386B; CCR2 antagonist (atherosclerosis), GlaxoSmithKline
|
||||
Indication | Atherosclerosis [ICD9: 414.0, 440; ICD10:I70] | Investigative | [543887] | ||
Company |
GlaxoSmithKline plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C12(CNc3c2ccc(c3)Cl)CCN(C[C@H]1O)C[C@H](C1CCN(CC1)C(=O)<br />/C=C/c1cc(cc(c1)F)F)O
|
||||
Target and Pathway | |||||
Target(s) | C-C chemokine receptor type 2 | Target Info | Antagonist | [543887] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.